Federal Circuit Upholds Moderna’s Patent Victory in COVID-19 Vaccine Case

In a significant legal development, the Federal Circuit has affirmed a decision favoring Moderna Inc. concerning its COVID-19 vaccine. The ruling comes after a Delaware federal judge’s interpretation of patent claims held by Alnylam Pharmaceuticals Inc., which led to the conclusion that Moderna’s vaccine does not infringe upon these patents. This decision marks a critical legal validation for Moderna amid ongoing scrutiny over intellectual property rights in the pharmaceutical industry. For further details, the full report is available on Law360.